By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for ETF State Street SPDR S&P Biotech ETF

State Street SPDR S&P Biotech ETF (XBI)

AMEX Currency in USD
$307.00
+$5.21
+1.73%
Last Update: 18 Jul 2026, 04:22
$10.21bn
Assets Under Management
35.00%
Expense Ratio
0.09%
Forward Dividend Yield
$216.75-$369.76
52 Week Range

XBI Price Chart

Explore State Street SPDR S&P Biotech ETF interactive price chart. Choose custom timeframes to analyze XBI price movements and trends.

XBI ETF Profile

Key details and information about State Street SPDR S&P Biotech ETF (XBI).

Sector Focus

Financial Services

Industry

Asset Management

Inception Date

6 Feb 2006

Country

US

Description

SPDR Series Trust - State Street SPDR S&P Biotech ETF is an exchange traded fund launched by State Street Global Advisors, Inc. The fund is managed by SSGA Funds Management, Inc. It invests in public equity markets of the United States. It invests in stocks of companies operating across health care, pharmaceuticals, biotechnology and life sciences sectors. The fund invests in growth and value stocks of companies across diversified market capitalization. It seeks to track the performance of the S&P Biotechnology Select Industry Index, by using representative sampling technique. SPDR Series Trust - State Street SPDR S&P Biotech ETF was formed on January 31, 2006 and is domiciled in the United States.

XBI ETF Performance

View XBI with an interactive analytics dashboard featuring price and candlestick charts, key metrics, holdings breakdowns, and dividend yield history. Open the template in Insights to customize and save it.

Explore Related ETFs

Discover other exchange-traded funds. Select a symbol to access its full profile.

Discover More
Command Palette
Search for a command to run